Technology
Nordic Bioscience neo-epitope biomarker technology
Nordic Bioscience's ProteinFingerPrint Technology™ is backed by more than 30 years of research and used by world-leading pharmaceutical companies. Our extracellular matrix-based approach quantifies disease activity with precision unmatched by omics providers, offering mechanistic and pharmacodynamic insights into tissue remodeling, a process crucial to understand when evaluating the effect of a therapeutic Intervention.
Inflammatory bowel disease, also known as IBD, is a chronic intestinal disease where neutrophils play a crucial role by producing and releasing calprotectin. Fecal calprotectin is a well-established biomarker for IBD, but low patient compliance with fecal sample collection has been a challenge.
Learn more about neutrophils, NETosis, calprotectin, and how a simple blood sample can assist patients, physicians, and clinicians to accurately quantify true neutrophil and disease activity in IBD and other chronic inflammatory diseases.
The Nordic Bioscience laboratory services are performed in compliance with international standards for GCP and GLP. Our operations are accredited by the College of American Pathologists (CAP). We have a long history of measuring and providing clinical data used by decision-makers to make vital decisions.
Our laboratory has the capacity to provide customized solutions. We have scientific biomarker experts, experienced project managers, and high-quality equipment to handle, plan and execute biomarker strategies across many levels in any organization - no project is too little, and no organization is too big.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
